Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosis

被引：6
|
作者：
Nichols, Derek [1 ]
Boyle, Theresa A. [2 ]
Noyes, David [1 ]
Latin, Kujtim [3 ]
Feygelman, Vladimir [3 ]
Jackson, Isabel [4 ]
Vujaskovic, Zeljko [4 ]
Antonia, Scott [1 ,5 ]
Perez, Bradford A. [1 ,2 ,3 ,5 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA
[4] Univ Maryland, Div Translat Radiat Sci, Dept Radiat Oncol, Sch Med, Baltimore, MD 21202 USA
[5] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 11期
关键词：
CELL LUNG-CANCER; NIVOLUMAB; SAFETY; PEMBROLIZUMAB; CHEMORADIATION; RADIOTHERAPY; CARBOPLATIN; IRRADIATION; IPILIMUMAB; CONCURRENT;
D O I：
10.21037/jtd.2018.10.01
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：6254 / +
页数：8
相关论文
共 50 条
  • [11] Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
    Park, Junseong
    Kim, Chang Gon
    Shim, Jin-Kyoung
    Kim, Jong Hoon
    Lee, Hoyoung
    Lee, Jae Eun
    Kim, Min Hwan
    Haam, Keeok
    Jung, Inkyung
    Park, Su-Hyung
    Chang, Jong Hee
    Shin, Eui-Cheol
    Kang, Seok-Gu
    ONCOIMMUNOLOGY, 2019, 8 (01):
  • [12] Stereotactic Radiation Therapy Combined With Anti-PD-1 Checkpoint Blockade Immunotherapy: Analysis of Clonal Diversity of Induced Antitumor Immune Responses
    Sharabi, A.
    Nirschl, C.
    Nirschl, T.
    Kochel, C.
    Francica, B.
    Velarde, E.
    DeWeese, T. L.
    Drake, C. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E95 - E95
  • [13] A potential biomarker for anti-PD-1 immunotherapy
    Goswami, Sangeeta
    Basu, Sreyashi
    Sharma, Padmanee
    NATURE MEDICINE, 2018, 24 (02) : 123 - 124
  • [14] A potential biomarker for anti-PD-1 immunotherapy
    Sangeeta Goswami
    Sreyashi Basu
    Padmanee Sharma
    Nature Medicine, 2018, 24 : 123 - 124
  • [15] Tumor Immunologic Heterogeneity Influences Response to Radiation and Anti-PD-1 Immunotherapy
    Aguilera, T. A.
    Rafat, M.
    Kariolis, M. S.
    Graves, E. E.
    Giaccia, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S211 - S211
  • [16] Anti-PD-1 Immunotherapy Potentiates the Radiation-Induced Lung Injury
    Xue, J.
    Du, S.
    Dicker, A. P.
    Lu, Y.
    Lu, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S205 - S205
  • [17] LASER TREATMENT AND ANTI-PD-1 IMMUNOTHERAPY PROLONG SURVIVAL IN A MOUSE MODEL OF SQUAMOUS CELL CARCINOMAS
    Christensen, Rikke L.
    Omland, Silje H.
    Lerche, Catharina M.
    Philipsen, Peter A.
    Olesen, Uffe H.
    Haedersdal, Merete
    LASERS IN SURGERY AND MEDICINE, 2022, 54 : S7 - S7
  • [18] Low-dose ipilimumab combined with anti-PD-1 immunotherapy in patients with metastatic melanoma following anti-PD-1 treatment failure
    Klee, Gina
    Kurzhals, Jonas
    Hagelstein, Victoria
    Zillikens, Detlef
    Recke, Andreas
    Langan, Ewan A.
    Terheyden, Patrick
    MELANOMA RESEARCH, 2021, 31 (05) : 464 - 471
  • [19] Evaluation of the antitumor activity of anti-PD-1 immunotherapy as a single agent and in combination with approved agents in preclinical tumor models
    Pinheiro, Elaine M.
    Mangadu, Ruban
    Phan, Uyen T.
    Cai, Mingmei
    Ma, Yanhong
    Hirsch, Heather A.
    McClanahan, Terrill K.
    Moniz, Raymond J.
    Al-Assaad, Ali-Samer
    Basu, Samik
    Wang, Yaolin
    Sriram, Venkataraman
    Phillips, Joseph H.
    Long, Brian J.
    CANCER RESEARCH, 2015, 75
  • [20] Prognostic significance of radiologic features of pneumonitis induced by anti-PD-1 therapy.
    Watanabe, Satoshi
    Ota, Takeshi
    Hayashi, Masachika
    Ishikawa, Hiroyuki
    Miyabayashi, Takao
    Terada, Masaki
    Sato, Kazuhiro
    Ishida, Takashi
    Tanaka, Hiroshi
    Iwashima, Akira
    Shoji, Satoshi
    Nozaki, Koichiro
    Ichikawa, Kosuke
    Kondo, Rie
    Yoshizawa, Hirohisa
    Kikuchi, Toshiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345